Evidence mapPaperPMID 40304988Full record

ReviewJournal of nephrology2025

Ketogenic diets in chronic kidney disease patients: a review for skeptics by skeptics.

Claudia D'Alessandro, Domenico Giannese, Giorgina Barbara Piccoli, Vincenzo Panichi, Adamasco Cupisti

Abstract readReview
In one paragraph

Review in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claudia D'AlessandroDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Domenico GianneseDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Giorgina Barbara PiccoliCentre Hospitalier Le Mans, Le Mans, France.
Vincenzo PanichiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Adamasco CupistiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. adamasco.cupisti@med.unipi.it.ORCID http://orcid.org/0000-0002-8995-936X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last few decades, there has been growing interest in the use of ketogenic diets, mainly as a weight loss strategy. Obesity and diabetes are major risk factors for kidney disease, and obese patients with chronic kidney disease (CKD) are potential candidates for weight reducing diets, among them ketogenic diets. Of further relevance to nephrology, a limited number of recent studies suggests a favorable effect of ketogenic diets in patients affected by autosomal dominant polycystic kidney disease (ADPKD). However, concerns remain about safety in patients with CKD, particularly in the long term and in those with poor residual kidney function. The confusion surrounding the definition of ketogenic diets adds to these concerns. The aim of this review is to summarize information on the main types of ketogenic diets used in daily practice and to discuss the options for their implementation in CKD patients, limiting ultra-processed or industrial preparations.Although further studies are needed to identify the profile of CKD patients who may benefit from the implementation of ketogenic diets to treat obesity or slow the progression of ADPKD, and to assess short- and long-term safety and adherence, the available data appear promising. This critical review is intended to stimulate further research.

Indexed as

Diet, KetogenicObesityPolycystic Kidney, Autosomal DominantRenal Insufficiency, ChronicHumansRisk FactorsTreatment OutcomeWeight LossChronic kidney diseaseKetogenic dietsObesityPolycystic kidney disease

Identifiers

PMID40304988
PMCPMC12378136

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.